Skip to main content

Table 5 Additional biopsies due to findings from CEM

From: Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions—a feasibility study

At least one additional biopsy (n = 47)

No

34 (72%)

Yes

13 (28%)

Biopsy led to changed treatment (n = 13)

No

6 (46%)

Yes

7 (54%)

Additional biopsies per patient

0

34 (72%)

1

9 (19%)

2

2 (4%)

3

2 (4%)

Total number of additional biopsies

19

Outcome from additional biopsies (n = 19)

Invasive cancer

6 (32%)

DCIS

3 (16%)

Benign

10 (53%)

  1. CEM contrast-enhanced mammography, DCIS ductal carcinoma in situ